BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 33595217)

  • 1. Oncologic Outcomes Following Robot-Assisted Radical Prostatectomy for Clinical T3 Prostate Disease.
    Zilberman DE; Abu-Ghanem Y; Raviv G; Rosenzweig B; Fridman E; Portnoy O; Dotan ZA
    Isr Med Assoc J; 2021 Feb; 23(2):111-115. PubMed ID: 33595217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cancer control outcomes in patients with clinically high-risk prostate cancer treated with robot-assisted radical prostatectomy: results from a multi-institutional study of 1100 patients.
    Abdollah F; Sood A; Sammon JD; Hsu L; Beyer B; Moschini M; Gandaglia G; Rogers CG; Haese A; Montorsi F; Graefen M; Briganti A; Menon M
    Eur Urol; 2015 Sep; 68(3):497-505. PubMed ID: 26119559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors and oncological outcomes of persistently elevated prostate-specific antigen in patients following robot-assisted radical prostatectomy.
    Kumar A; Samavedi S; Mouraviev V; Bates AS; Coelho RF; Rocco B; Patel VR
    J Robot Surg; 2017 Mar; 11(1):37-45. PubMed ID: 27245233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes at 10 years following robotic radical prostatectomy.
    Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
    Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic Outcomes After Robot-assisted Radical Prostatectomy: A Large European Single-centre Cohort with Median 10-Year Follow-up.
    Rajan P; Hagman A; Sooriakumaran P; Nyberg T; Wallerstedt A; Adding C; Akre O; Carlsson S; Hosseini A; Olsson M; Egevad L; Wiklund F; Steineck G; Wiklund NP
    Eur Urol Focus; 2018 Apr; 4(3):351-359. PubMed ID: 28753802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical recurrence-free survival after robotic-assisted laparoscopic vs open radical prostatectomy for intermediate- and high-risk prostate cancer.
    Ritch CR; You C; May AT; Herrell SD; Clark PE; Penson DF; Chang SS; Cookson MS; Smith JA; Barocas DA
    Urology; 2014 Jun; 83(6):1309-15. PubMed ID: 24746665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation.
    Thompson JE; Sridhar AN; Shaw G; Rajan P; Mohammed A; Briggs TP; Nathan S; Kelly JD; Sooriakumaran P
    BMC Urol; 2020 Jul; 20(1):81. PubMed ID: 32611411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of biochemical recurrence based on extent and location of positive surgical margins after robot-assisted laparoscopic radical prostatectomy.
    Marcq G; Michelet A; Hannink G; Rizk J; Sauvain J; Villers A; Saffarini M; Rochat CH
    BMC Cancer; 2018 Dec; 18(1):1291. PubMed ID: 30587172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
    Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H
    BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing High-Intensity Focal Ultrasound Hemiablation to Robotic Radical Prostatectomy in the Management of Unilateral Prostate Cancer: A Matched-Pair Analysis.
    Albisinni S; Aoun F; Bellucci S; Biaou I; Limani K; Hawaux E; Peltier A; van Velthoven R
    J Endourol; 2017 Jan; 31(1):14-19. PubMed ID: 27799004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First Postprostatectomy Ultrasensitive Prostate-specific Antigen Predicts Survival in Patients with High-risk Prostate Cancer Pathology.
    Kang JJ; Reiter RE; Steinberg ML; King CR
    Eur Urol Oncol; 2018 Oct; 1(5):378-385. PubMed ID: 31158076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detectable Prostate-specific antigen value between 0.01 and 0.1 ng/ml following robotic-assisted radical prostatectomy (RARP): does it correlate with future biochemical recurrence?
    Zakaria AS; Schwartz RN; Hodhod A; Couture F; Tholomier C; Shahine H; Negrean C; Nguyen DD; Zanaty M; Stolzenbach F; Karakiewicz PI; El-Hakim A; Zorn KC
    World J Urol; 2021 Jun; 39(6):1853-1860. PubMed ID: 32696130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can robot-assisted laparoscopic radical prostatectomy (RALP) be performed very soon after biopsy?
    Jo JK; Oh JJ; Lee S; Jeong SJ; Hong SK; Byun SS; Lee SE
    World J Urol; 2017 Apr; 35(4):605-612. PubMed ID: 27480545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perioperative parameters and prognosis analysis of patients aged 80 years or older treated with radical prostatectomy for prostate cancer].
    Zhang F; Zhang SD; Xiao CL; Huang Y; Ma LL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):822-827. PubMed ID: 30337742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Variations in Prostatic Apex Shape on Apical Margin Positive Rate After Radical Prostatectomy: Robot-Assisted Laparoscopic Radical Prostatectomy vs Open Radical Prostatectomy.
    Yu YD; Lee M; Hong SK; Byun SS; Lee SE; Lee S
    J Endourol; 2018 Jan; 32(1):46-53. PubMed ID: 29212368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in clinical and oncological outcomes of robot-assisted radical prostatectomy before and after the 2012 US Preventive Services Task Force recommendation against PSA screening: a decade of experience.
    Seetharam Bhat KR; Moschovas MC; Onol FF; Sandri M; Rogers T; Roof S; Rocco B; Patel VR
    BJU Int; 2020 Jun; 125(6):884-892. PubMed ID: 32173990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.